Articles From: WSFS Financial Corporation Announces CFO Transition to Actavis Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 2014; Non-GAAP EPS Increases 23% to $3.91; Increases 2015 Standalone Forecast


2015/2/19
WILMINGTON, Del., Feb.
Sign-up for WSFS Financial Corporation Announces CFO Transition investment picks
2015/2/19
NORWOOD, Mass., Feb.
Sign-up for Xcerra Announces Second Quarter Earnings Release Date and Conference Call investment picks
2015/2/19
Conference call to be held today at 4:30 p.m. ET MONROVIA, Calif.
Sign-up for Xencor Reports Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/19
BURNABY, British Columbia, Feb.
Sign-up for Xenon Pharmaceuticals' Partner Teva to Initiate Phase 2b Clinical Trial of TV-45070 in Post-Herpetic Neuralgia investment picks
2015/2/19
XenoPort, Inc. (Nasdaq:XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2014.
Sign-up for XenoPort Reports Fourth Quarter and Year-End 2014 Financial Results investment picks
2015/2/19
Today, Yahoo, Inc. (Nasdaq: YHOO ) is hosting more than a thousand developers, at the first Yahoo Mobile Developer Conference at the Nob Hill Masonic Center in San Francisco.
Sign-up for Yahoo Announces New Mobile Developer Suite at First Yahoo Mobile Developer Conference investment picks
2015/2/19
By Dominic Chopping Norwegian fertilizer producer Yara ASA (YAR.OS) and German chemical group BASF (BAS.XE) have Thursday agreed to build an ammonia plant at BASF's site in Freeport, Texas as the companies look to increase their footprint and take advantage of attractive raw material costs in the U.S. Yara said total capital investment for the plant is seen at $600 million, but it will in addition build an ammonia tank at the BASF terminal bringing Yara's total investment to $490 million.
Sign-up for Yara and BASF To Build Ammonia Plant In Texas investment picks
2015/2/19
SAN FRANCISCO , Feb.
Sign-up for Yelp Announces Schedule of Upcoming Investor Conferences investment picks
2015/2/19
http://www.ccnmatthews.com/logos/20110120-zargon_200.jpg CALGARY, ALBERTA --
Sign-up for Zargon Oil & Gas Ltd. Announces 2014 Year End Reserves and Provides a Little Bow ASP Project Update investment picks
2015/2/19
Company to host conference call on March 17, 2015 Management notes sales strength in both Zebra and Enterprise LINCOLNSHIRE, Ill.
Sign-up for Zebra Technologies Updates Date for 2014 Fourth Quarter and Full Year Earnings Announcement investment picks
2015/2/19
– As ZS-9 Nears NDA and MAA Submissions, ZS Pharma Adds Key Members to Its Medical Affairs and Commercial Leadership Team – REDWOOD CITY, Calif., Feb.
Sign-up for ZS Pharma Hires Key Medical Affairs and Commercial Executives investment picks
2015/2/19
No minimum bids or reserve prices on late-model farm equipment, construction equipment and trucks FORT WORTH, TEXAS , Feb.
Sign-up for 2,300+ equipment items to be sold at Ritchie Bros. unreserved public auction in Fort Worth, Texas investment picks
2015/2/19
3M announced today that it has entered into a definitive agreement to acquire Ivera Medical Corp., a manufacturer of health care products that disinfect and protect devices used for access into a patient’s bloodstream.
Sign-up for 3M to Acquire Ivera Medical Corp. investment picks
2015/2/18
In an effort to improve the quality of life for its beneficiaries with diabetes and reduce the growing costs associated with treating the condition, Cigna-HealthSpring has partnered with Telcare to further expand health care services for its Texas Medicaid STAR+PLUS membership.
Sign-up for A First in Texas Medicaid, Cigna-HealthSpring Partners with Telcare to Bring Cellular-Enabled Monitoring and Engagement to Beneficiaries with Diabetes investment picks
2015/2/18
A10 Networks, Inc. (NYSE:ATEN), a technology leader in application networking, today announced that management will participate in the following upcoming investor conference.
Sign-up for A10 Networks, Inc. to Participate in Upcoming Investor Conference investment picks
2015/2/18
( Click to Tweet this News ) Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that the Company’s data have been selected for an oral platform presentation at the American Academy of Neurology (AAN) 67 th Annual Meeting being held in Washington, D.C. The abstract, titled “Orally-administered TRPV1 and TRPA1 activators inhibit electrically-induced muscle cramps in normal healthy volunteers, ” will be presented on Tuesday, April 21, 2015, from 3:45 to 4:00 p.m. “These results support our belief that this treatment has significant potential as a solution for people suffering from sports-related muscle cramping, nocturnal leg cramps, as well as muscle cramping and spasms resulting from of
Sign-up for AAN Selects Flex Pharma Data for Oral Platform Presentation investment picks
2015/2/18
BANGALORE , February 18, 2015 /PRNewswire/ -- Infosys (NYSE: INFY) , a global leader in consulting, technology, outsourcing and next-generation services, today announced a multi-year, multimillion-dollar partnership with ABN AMRO , a leading retail and commercial bank, to provide IT services for the bank's operations.
Sign-up for ABN AMRO Selects Infosys as One of the Strategic Partners to Drive its Business Transformation Program investment picks
2015/2/18
Absolute Computrace delivers automated security capabilities for offline devices VANCOUVER , Feb.
Sign-up for Absolute Software Introduces Device Freeze Offline Policy investment picks
2015/2/18
Absolute Software Introduces Device Freeze Offline Policy Canada NewsWire VANCOUVER , Feb.
Sign-up for Absolute Software Introduces Device Freeze Offline Policy investment picks
2015/2/18
Accenture (NYSE:ACN) has been named a leader in outsourced testing services in the Ovum Decision Matrix: Selecting an Outsourced Testing Service Provider, 2014–15 .
Sign-up for Accenture Named a Market Leader by Ovum for Outsourced Testing Services investment picks
2015/2/18
Accenture (NYSE:ACN) today announced that it has received both the Global and Americas VMware Partner Network Award in the Consulting and Integration Partner of the Year category.
Sign-up for Accenture Receives Two Consulting and Integration Partner of the Year Awards at VMware Partner Exchange 2015 investment picks
2015/2/18
By Ruth Bender PARIS-- Accor SA is ready to pursue more acquisitions to ramp up its digital know-how as the French hotel group tries to fight back against the growing dominance of online booking portals.
Sign-up for Accor Hopes to Counter Growing Dominance of Online Booking Portals investment picks
2015/2/18
PARIS--Accor SA Wednesday said the group's turnaround efforts bore their first fruits in 2014 as the French hotels group reported a jump in full-year profit.
Sign-up for Accor Posts 77% Rise in Full-Year Net Profit investment picks
2015/2/18
NEW HAVEN, Conn., Feb.
Sign-up for Achillion Pharmaceuticals Announces Closing of Public Offering of Common Stock investment picks
2015/2/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1175561&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for Achronix Dramatically Reduces Compile Times With New Incremental Compile Support in Its ACE Design Tools investment picks
2015/2/18
The Premier British TV Streaming Service in North America Exclusively premieres the acclaimed BBC period drama Starring Jessica Brown Findlay ( Downton Abbey) , Matthew McNulty, and Sean Harris SILVER SPRING, Md., Feb.
Sign-up for Acorn TV's New Miniseries - Jamaica Inn - Makes Its US Debut on Monday, March 16, 2015 investment picks
2015/2/18
- Unites Global Brand Portfolio Under Allergan Name - - Retains Actavis Name for Select Geographic Regions and Product Portfolios- - Recognizes Heritage and Customer Equity of Both Names - - Company to Operate Under Unified Management Team, Single Vision and Culture - - Shareholder Approval Required - DUBLIN , Feb.
Sign-up for Actavis Announces Intention to Adopt "Allergan" Corporate Name investment picks
2015/2/18
By Michael Calia Actavis PLC raised its profit guidance for 2015, while acquisitions again helped drive revenue growth in the fourth quarter, as the company awaits the close of its deal to buy Botox maker Allergan Inc. The results easily surpassed analysts' expectations.
Sign-up for Actavis Earnings Soar as Closing of Allergan Deal Looms investment picks
2015/2/18
By Michael Calia Actavis PLC on Wednesday said it plans to change its name to Allergan, the moniker of the Botox maker it has agreed to acquire.
Sign-up for Actavis Earnings Soar as Closing of Allergan Deal Looms -- Update investment picks
2015/2/18
- Adjusted EBITDA Increases 80% to $1.5 Billion in Fourth Quarter 2014 - - $12.8 Billion Full Year Non-GAAP Net Revenue Increases 48% - - $4.5 Billion Full Year Adjusted EBITDA Increases 99% - - Exceptional Performance across Global Businesses - - GAAP Loss per Diluted Share in Fourth Quarter of $2.76 - - Standalone 2015 Forecast Raised to $16.30-$17.30 - DUBLIN , Feb.
Sign-up for Actavis Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 2014; Non-GAAP EPS Increases 23% to $3.91; Increases 2015 Standalone Forecast investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: WSFS Financial Corporation Announces CFO Transition to Actavis Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 2014; Non-GAAP EPS Increases 23% to $3.91; Increases 2015 Standalone Forecast
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent